• Users Online: 19
  • Print this page
  • Email this page
REVIEW ARTICLE
Year : 2021  |  Volume : 6  |  Issue : 1  |  Page : 17-21

A comprehensive review on vitiligo and its pharmacotherapy: Recent trends and future challenges


1 Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Asha 31982, Saudi Arabia
2 Postgraduate Student, Collage of Pharmacy, Jazan University, Saudi Arabia
3 Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Asha 31982; Professor, Department of Pharmaceutics, Vidya Siri College of Pharmacy, Bengaluru, Karnataka, India, Saudi Arabia

Correspondence Address:
Ms. Asmaa Moafa
Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982
Saudi Arabia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijmo.ijmo_15_20

Rights and Permissions

Approximately 1% of population in the world is affected by an intriguing skin depigmentation disorder, vitiligo. Typically, a vitiligo lesions are seen as white milky, nonscaly patches with separate edges. Vitiligo is caused by a selective loss of epidermal melanocytes. In vitiligo, there is impaired melanocyte regeneration and/or multiplication. Although the proportion of the population affected by this disease is very low, the disease is associated with a lot of social stigmas. This defect has an important effect on the life of the patient and still a persistent load.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed970    
    Printed45    
    Emailed0    
    PDF Downloaded64    
    Comments [Add]    

Recommend this journal